Gilead commercial boss Kevin Young to retire Feb. 4

... Young joined Foster City-based Gilead (NASDAQ: GILD), the worldwide leader in developing and selling drugs to treat HIV/AIDS patients, the company's annual revenue hit $1.24 billion. That number is expected to jump to more than $10 billion in 2013, ...

http://www.bizjournals.com/sanfrancisco/blog/biotech/2014/01/gilead-gild-kevin-young-retire-sovaldi.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+bizj_national+%28Bizjournals+National+Feed%29